Skip to main content

Boston Scientific settles global heart valve legal battles for $180M

The tools Boston Scientific and Edwards Lifesciences have battled over are used during a relatively new, multibillion-dollar cardiac treatment called transcatheter aortic valve replacement (TAVR).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.